» Articles » PMID: 7689871

Megakaryocytic Differentiation Induced in 416B Myeloid Cells by GATA-2 and GATA-3 Transgenes or 5-azacytidine is Tightly Coupled to GATA-1 Expression

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1993 Sep 1
PMID 7689871
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The GATA 'zinc-finger' transcription factors are thought to have important roles in the control of hematopoiesis. GATA-1 and GATA-2 are found in the erythroid, mast cell, and megakaryocytic lineages, and GATA-3 in T lymphocytes. GATA-1 is required for erythroid development and has recently been shown by gene transfer to direct megakaryocytic differentiation of the primitive myeloid cell line 416B. Here we show that enforced expression in 416B cells of either the GATA-2 or GATA-3 gene also induces megakaryocytic differentiation, as assessed by cellular morphology, acetylcholinesterase activity, polyploid DNA content, and loss of Mac-1 expression. No erythroid or mast cell differentiation was found. Unexpectedly, the level of endogenous GATA-1 mRNA had increased 20- to 30-fold among the transfectants, whereas that of GATA-2 mRNA was unaltered and endogenous GATA-3 transcripts remained undetectable. This finding suggests that GATA-2 and GATA-3 lie upstream of GATA-1 in a regulatory hierarchy and that, in 416B cells, GATA-1 may mediate the phenotypic changes induced by GATA-2 or GATA-3. Furthermore, 416B cells treated with the DNA demethylating agent 5-azacytidine underwent megakaryocytic differentiation accompanied by a marked increase in the level of GATA-1 mRNA but not that of GATA-2 or GATA-3. These results strongly implicate GATA factors in megakaryocytic differentiation and suggest that, at least for 416B cells, GATA-1 is a dominant regulator of maturation along this lineage.

Citing Articles

GATA1 in Normal and Pathologic Megakaryopoiesis and Platelet Development.

Takasaki K, Chou S Adv Exp Med Biol. 2024; 1459:261-287.

PMID: 39017848 DOI: 10.1007/978-3-031-62731-6_12.


DNA microarray expression profiling of a new t(8;13) AML case allows identification of possible leukemogenic transformation markers.

Pozzo A, DE Faria F, De Carvalho L, Pinho M, Maia R Rev Bras Hematol Hemoter. 2017; 39(4):368-371.

PMID: 29150113 PMC: 5693272. DOI: 10.1016/j.bjhh.2017.06.003.


Reconstructing blood stem cell regulatory network models from single-cell molecular profiles.

Hamey F, Nestorowa S, Kinston S, Kent D, Wilson N, Gottgens B Proc Natl Acad Sci U S A. 2017; 114(23):5822-5829.

PMID: 28584094 PMC: 5468644. DOI: 10.1073/pnas.1610609114.


Divergent functions of hematopoietic transcription factors in lineage priming and differentiation during erythro-megakaryopoiesis.

Pimkin M, Kossenkov A, Mishra T, Morrissey C, Wu W, Keller C Genome Res. 2014; 24(12):1932-44.

PMID: 25319996 PMC: 4248311. DOI: 10.1101/gr.164178.113.


Structural and functional conservation of CLEC-2 with the species-specific regulation of transcript expression in evolution.

Wang L, Ren S, Zhu H, Zhang D, Hao Y, Ruan Y Glycoconj J. 2012; 29(5-6):335-45.

PMID: 22740230 DOI: 10.1007/s10719-012-9415-0.